Lorenzo Gervaso

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Re-challenge strategies in neuroendocrine tumours: adding another arrow in the quiver?

Re-challenge strategies in neuroendocrine tumours: adding another arrow in the quiver?

Journal: Cancer treatment reviews

Published: April 18, 2026

Management of cancer-associated thrombosis in patients with gastrointestinal cancers: lights and shadows.

Management of cancer-associated thrombosis in patients with gastrointestinal cancers: lights and shadows.

Journal: Cancer treatment reviews

Published: February 08, 2026

Diagnostic and Therapeutic Challenges Related to HER2 Heterogeneity in Gastric Cancer: Bridging Molecular Pathology and Clinical Decision-Making.

Diagnostic and Therapeutic Challenges Related to HER2 Heterogeneity in Gastric Cancer: Bridging Molecular Pathology and Clinical Decision-Making.

Journal: International journal of molecular sciences

Published: January 11, 2026

Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center.

Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 09, 2026

Preliminary results of a prospective study on FAPi-PET for staging of locally advanced gastric cancer.

Preliminary results of a prospective study on FAPi-PET for staging of locally advanced gastric cancer.

Journal: Updates in surgery

Published: December 28, 2025

Anti-EGFR rechallenge compared with standard of care for patients with ctDNA RAS/BRAF wild-type chemorefractory metastatic colorectal cancer: A systematic review and meta-analysis.

Anti-EGFR rechallenge compared with standard of care for patients with ctDNA RAS/BRAF wild-type chemorefractory metastatic colorectal cancer: A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: November 27, 2025

Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project.

Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project.

Journal: International journal of epidemiology

Published: October 27, 2025

Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancer.

Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancer.

Journal: Cancer treatment and research communications

Published: September 29, 2025

Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.

Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: May 15, 2025

Systemic Therapies for Advanced Hepatocellular Carcinoma: Which Gaps Should We Try to Fill?

Systemic Therapies for Advanced Hepatocellular Carcinoma: Which Gaps Should We Try to Fill?

Journal: JCO oncology practice

Published: April 11, 2025

Navigating the clinical challenges of zolbetuximab in patients with claudin positive advanced gastric cancer.

Navigating the clinical challenges of zolbetuximab in patients with claudin positive advanced gastric cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 19, 2025

Molecular tumour board in gastrointestinal cancers.

Molecular tumour board in gastrointestinal cancers.

Journal: ESMO open

Published: January 21, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026